Ovarian cancer most commonly presents as high-grade serous ovarian carcinoma (HGSOC), which contains p53 mutation in at least 94% of cases [32, 33], sporadic BRCA1 or BRCA2 mutations in <15% of cases. This evidence concerns the gene BRCA2 and ovarian serous carcinoma.